Close Menu

NEW YORK (GenomeWeb) –The Centers for Medicare & Medicaid Services released a final rule this week for public comment revising its controversial 14-day rule that has long hindered molecular diagnostics labs from directly billing the government payor when tests are ordered within two weeks of an outpatient's discharge from the hospital.

Get the full story with
Premium Access

Only $95 for the
first 90 days*

Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try Premium Access now.

You may already have institutional access!

Check if I qualify.

Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.